Reaction

Ocular Procedural Complication reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 193 reports · 2 co-occurring drugs

As of the last recalculation, Ocular Procedural Complication appears in 193 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (PRR 161.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Losartan Potassium And Hydrochlorothiazide16161.9162.1
Aflibercept32132.4132.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.